An approach to addressing depression in patients with chronic kidney disease.
Depressive symptoms and clinical depression are commonly noted in patients with end-stage renal disease and chronic kidney disease (not on dialysis). This association is important since depressive symptoms have been associated with both an impaired quality of life and increased morbidity and mortality. It is, therefore, important to develop strategies to screen patients with chronic kidney disease for depression and to develop strategies to treat clinical depression in this group of patients.
Finkelstein
Fredric O
FO
Renal Research Institute, New Haven, Conn., USA. fof@comcast.net
Wuerth
Diane
D
Finkelstein
Susan H
SH
D000928:Antidepressive Agents / Q000627:therapeutic use; D001007:Anxiety / Q000209:etiology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003376:Counseling; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D005081:Exercise Therapy; D005195:Family Relations; D006801:Humans; D007674:Kidney Diseases / Q000523:psychology* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000523:psychology / Q000628:therapy; D011379:Prognosis; D011613:Psychotherapy; D011788:Quality of Life; D017582:Renal Replacement Therapy / Q000523:psychology; D012893:Sleep Wake Disorders / Q000150:complications / Q000523:psychology; D012944:Social Support; D013315:Stress, Psychological / Q000209:etiology
D000928:Antidepressive Agents